Avalon Pharma Q1 Profit SAR 26.9 Million

About this update from Middle East Pharmaceutical Industries Company

Middle East Pharmaceutical Industries Company SJSC TADAWUL:4016:AVALON PHARMA Q1 SALES SAR 130.13 MILLIONAVALON PHARMA Q1 NET PROFIT SAR 26.9 MILLIONAVALON PHARMA- QUARTER SAW OVERALL GROWTH REMAINED RESILIENT DESPITE GEOPOLITICAL DISRUPTIONSAVALON PHARMA- QUARTER SAW EXPORT SALES REFLECTED A TEMPORARY REPHASING IMPACTAVALON PHARMA- QUARTER SAW NEW CUSTOMER ONBOARDING, STRONGER SELL-OUT RATES, TARGETED TRADE ACTIVATION INITIATIVES

View stock analysis, news, and events for Middle East Pharmaceutical Industries Company